Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
BeiGene Ltd ( (HK:6160) ) has shared an announcement.
BeiGene, Ltd. has issued an overseas regulatory announcement regarding an amendment to its Form 10-K/A, filed with the U.S. Securities and Exchange Commission. The announcement signifies the company’s compliance with regulatory filing requirements, which is crucial for maintaining its listing on multiple stock exchanges and ensuring transparency with investors.
More about BeiGene Ltd
BeiGene, Ltd. is a global biotechnology company focused on the research and development of innovative oncology therapies. The company is incorporated in the Cayman Islands and its securities are traded on the NASDAQ Global Select Market and The Stock Exchange of Hong Kong Limited.
YTD Price Performance: -3.30%
Average Trading Volume: 2,004,706
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$155.3B
See more insights into 6160 stock on TipRanks’ Stock Analysis page.
Trending Articles
- Apple Settles $95M Class Action Suit and Clears Siri’s Privacy Norms
- Biden Plans One Last Chip Export Curb on Nvidia Before Leaving Office
- 3 Penny Stocks to Watch Now, 1/9/25
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
